View Item 

Show simple item record

Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas
dc.contributor.authorKierans, Andrea S.
dc.contributor.authorLafata, Kyle J.
dc.contributor.authorLudwig, Daniel R.
dc.contributor.authorBurke, Lauren M. B.
dc.contributor.authorChernyak, Victoria
dc.contributor.authorFowler, Kathryn J.
dc.contributor.authorFraum, Tyler J.
dc.contributor.authorMcGinty, Katrina A.
dc.contributor.authorMcInnes, Matthew D. F.
dc.contributor.authorMendiratta-Lala, Mishal
dc.contributor.authorCunha, Guilherme Moura
dc.contributor.authorAllen, Brian C.
dc.contributor.authorHecht, Elizabeth M.
dc.contributor.authorJaffe, Tracy A.
dc.contributor.authorKalisz, Kevin R.
dc.contributor.authorRanathunga, Damithri S.
dc.contributor.authorWildman-Tobriner, Benjamin
dc.contributor.authorCardona, Diana M.
dc.contributor.authorAslam, Anum
dc.contributor.authorGaur, Sonia
dc.contributor.authorBashir, Mustafa R.
dc.date.accessioned2023-01-11T16:25:19Z
dc.date.available2024-02-11 11:25:16en
dc.date.available2023-01-11T16:25:19Z
dc.date.issued2023-01
dc.identifier.citationKierans, Andrea S.; Lafata, Kyle J.; Ludwig, Daniel R.; Burke, Lauren M. B.; Chernyak, Victoria; Fowler, Kathryn J.; Fraum, Tyler J.; McGinty, Katrina A.; McInnes, Matthew D. F.; Mendiratta-Lala, Mishal ; Cunha, Guilherme Moura; Allen, Brian C.; Hecht, Elizabeth M.; Jaffe, Tracy A.; Kalisz, Kevin R.; Ranathunga, Damithri S.; Wildman-Tobriner, Benjamin ; Cardona, Diana M.; Aslam, Anum; Gaur, Sonia; Bashir, Mustafa R. (2023). "Comparing Survival Outcomes of Patients With LI- RADS- M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas." Journal of Magnetic Resonance Imaging 57(1): 308-317.
dc.identifier.issn1053-1807
dc.identifier.issn1522-2586
dc.identifier.urihttps://hdl.handle.net/2027.42/175478
dc.publisherJohn Wiley & Sons, Inc.
dc.subject.otherHCC
dc.subject.otherLI-RADS M
dc.subject.otherMRI
dc.subject.otheroverall survival
dc.subject.otherprogression free survival
dc.titleComparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175478/1/jmri28218_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/175478/2/jmri28218.pdf
dc.identifier.doi10.1002/jmri.28218
dc.identifier.sourceJournal of Magnetic Resonance Imaging
dc.identifier.citedreferenceChoi SH, Lee SS, Park SH, et al. LI-RADS classification and prognosis of primary liver cancers at gadoxetic acid-enhanced MRI. Radiology 2019; 290 ( 2 ): 388 - 397.
dc.identifier.citedreferenceDhanasekaran R, Hemming AW, Zendejas I, et al. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep 2013; 29 ( 4 ): 1259 - 1267.
dc.identifier.citedreferenceLi YY, Li H, Lv P, et al. Prognostic value of cirrhosis for intrahepatic cholangiocarcinoma after surgical treatment. J Gastrointest Surg 2011; 15 ( 4 ): 608 - 613.
dc.identifier.citedreferenceHyder O, Marques H, Pulitano C, et al. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: An eastern and Western experience. JAMA Surg 2014; 149 ( 5 ): 432 - 438.
dc.identifier.citedreferenceLi SQ, Liang LJ, Hua YP, et al. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma. Chin Med J (Engl) 2009; 122 ( 19 ): 2286 - 2291.
dc.identifier.citedreferenceKierans AS, Leonardou P, Hayashi P, et al. MRI findings of rapidly progressive hepatocellular carcinoma. Magn Reson Imaging 2010; 28 ( 6 ): 790 - 796.
dc.identifier.citedreferencePoultsides GA, Zhu AX, Choti MA, Pawlik TM. Intrahepatic cholangiocarcinoma. Surg Clin North Am 2010; 90 ( 4 ): 817 - 837.
dc.identifier.citedreferenceChoi SY, Kim SH, Park CK, et al. Imaging features of gadoxetic acid-enhanced and diffusion-weighted MR imaging for identifying cytokeratin 19-positive hepatocellular carcinoma: A retrospective observational study. Radiology 2018; 286 ( 3 ): 897 - 908.
dc.identifier.citedreferenceTakahashi K, Obeid J, Burmeister CS, et al. Intrahepatic cholangiocarcinoma in the liver explant after liver transplantation: Histological differentiation and prognosis. Ann Transplant 2016; 21: 208 - 215.
dc.identifier.citedreferencePinyol R, Montal R, Bassaganyas L, et al. Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial. Gut 2019; 68 ( 6 ): 1065 - 1075.
dc.identifier.citedreferenceLencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010; 30 ( 1 ): 52 - 60.
dc.identifier.citedreferenceAmerican College of Radiology. CT/MRI LI-RADS version 2018. Accessed April 8 2021. Available from: https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LI-RADS-2018-Core.pdf
dc.identifier.citedreferenceKim DH, Choi SH, Park SH, et al. Liver imaging reporting and data system category M: A systematic review and meta-analysis. Liver Int 2020; 40 ( 6 ): 1477 - 1487.
dc.identifier.citedreferencevan der Pol CB, Lim CS, Sirlin CB, et al. Accuracy of the liver imaging reporting and data system in computed tomography and magnetic resonance image analysis of hepatocellular carcinoma or overall malignancy-a systematic review. Gastroenterology 2019; 156 ( 4 ): 976 - 986.
dc.identifier.citedreferenceAn C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ. Single hepatocellular carcinoma: Preoperative MR imaging to predict early recurrence after curative resection. Radiology 2015; 276 ( 2 ): 433 - 443.
dc.identifier.citedreferenceBruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42 ( 5 ): 1208 - 1236.
dc.identifier.citedreferenceSakamoto Y, Kokudo N, Matsuyama Y, et al. Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the liver cancer study Group of Japan. Cancer 2016; 122 ( 1 ): 61 - 70.
dc.identifier.citedreferenceKong J, Cao Y, Chai J, et al. Effect of tumor size on long-term survival after resection for solitary intrahepatic cholangiocarcinoma. Front Oncol 2020; 10: 559911.
dc.identifier.citedreferenceBrar G, Greten TF, Graubard BI, et al. Hepatocellular carcinoma survival by etiology: A SEER-Medicare database analysis. Hepatol Commun 2020; 4 ( 10 ): 1541 - 1551.
dc.identifier.citedreferenceKudo M. Surveillance, diagnosis, and treatment outcomes of hepatocellular carcinoma in Japan: 2021 update. Liver Cancer 2021; 10 ( 3 ): 167 - 180.
dc.identifier.citedreferenceWang C-Y, Li S. Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China. Medicine 2019; 98 ( 4 ): e14070.
dc.identifier.citedreferenceKobayashi M, Ikeda K, Saitoh S, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88 ( 11 ): 2471 - 2477.
dc.identifier.citedreferenceYamamoto S, Kubo S, Hai S, et al. Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95 ( 7 ): 592 - 595.
dc.identifier.citedreferenceChang KY, Chang JY, Yen Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Canc Netw 2009; 7 ( 4 ): 423 - 427.
dc.identifier.citedreferenceTovoli F, Guerra P, Iavarone M, et al. Surveillance for hepatocellular carcinoma also improves survival of incidentally detected intrahepatic cholangiocarcinoma arisen in liver cirrhosis. Liver Cancer 2020; 9 ( 6 ): 744 - 755.
dc.identifier.citedreferenceTyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011; 54 ( 1 ): 173 - 184.
dc.identifier.citedreferenceJesper D, Heyn SG, Schellhaas B, et al. Effects of liver cirrhosis and patient condition on clinical outcomes in intrahepatic cholangiocarcinoma: A retrospective analysis of 156 cases in a single center. Eur J Gastroenterol Hepatol 2018; 30 ( 5 ): 552 - 556.
dc.identifier.citedreferenceLuo X, Yuan L, Wang Y, Ge R, Sun Y, Wei G. Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: A large single-center cohort study. J Gastrointest Surg 2014; 18 ( 3 ): 562 - 572.
dc.identifier.citedreferenceGuglielmi A, Ruzzenente A, Campagnaro T, et al. Intrahepatic cholangiocarcinoma: Prognostic factors after surgical resection. World J Surg 2009; 33 ( 6 ): 1247 - 1254.
dc.identifier.citedreferenceOhtsuka M, Ito H, Kimura F, et al. Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003; 10 ( 4 ): 259 - 264.
dc.identifier.citedreferenceWeber SM, Jarnagin WR, Klimstra D, DeMatteo RP, Fong Y, Blumgart LH. Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001; 193 ( 4 ): 384 - 391.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jmri28218_am.pdf
Size:
1.970MB
Format:
PDF
View/Open
Name:
jmri28218.pdf
Size:
1.353MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.